| 2024-05-15 13:31 | CC:PHRX | Pharmadrug Inc (2) | 0.035 | News Release200 | Pharmadrug units submits PD-001 study application |
| 2024-05-13 13:04 | CC:PHRX | Pharmadrug Inc (2) | 0.03 | Shareholders Letter212 | Pharmadrug CEO talks synthetic cocaine manufacturing |
| 2024-05-02 16:56 | CC:PHRX | Pharmadrug Inc (2) | 0.03 | News Release200 | Pharmadrug appoints Goldman as director, Vassev resigns |
| 2024-05-01 13:37 | CC:PHRX | Pharmadrug Inc (2) | 0.03 | News Release200 | Pharmather, Pharmadrug complete PD-001 clinical package |
| 2024-04-29 07:36 | CC:PHRX | Pharmadrug Inc (2) | 0.03 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-04-29 04:46 | CC:PHRX | Pharmadrug Inc (2) | 0.03 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-04-16 14:37 | CC:PHRX | Pharmadrug Inc (2) | 0.035 | News Release200 | Pharmadrug to refine cocaine synthesis method |
| 2024-03-13 10:54 | CC:PHRX | Pharmadrug Inc (2) | 0.06 | News Release200 | Pharmadrug files patent for manufacturing of cocaine |
| 2024-02-27 12:09 | CC:PHRX | Pharmadrug Inc (2) | 0.06 | News Release200 | Pharmadrug appoints Kideckel as chairman |
| 2024-02-21 13:19 | CC:PHRX | Pharmadrug Inc (2) | 0.055 | News Release200 | Pharmather, Pharmadrug begin Sairiyo plan for PD-001 |
| 2024-02-14 13:15 | CC:PHRX | Pharmadrug Inc (2) | 0.06 | News Release200 | Pharmadrug unit to manufacture PD-001 for human studies |
| 2024-02-12 11:58 | CC:PHRX | Pharmadrug Inc (2) | 0.065 | News Release200 | Pharmadrug hires marketing, IR service providers |
| 2024-02-08 16:43 | CC:PHRX | Pharmadrug Inc (2) | 0.05 | News Release200 | Pharmadrug closes $326,000 private placement |
| 2024-02-01 12:23 | CC:PHRX | Pharmadrug Inc (2) | 0.04 | News Release200 | Pharmadrug arranges $326,000 private placement |
| 2023-12-13 13:16 | CC:PHRX | Pharmadrug Inc (2) | 0.045 | Shareholders Letter212 | Pharmadrug CEO details Securedose acquisition |
| 2023-11-29 17:38 | CC:PHRX | Pharmadrug Inc (2) | 0.04 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-15 14:37 | CC:PHRX | Pharmadrug Inc (2) | 0.04 | News Release200 | Pharmadrug closes debt restructuring |
| 2023-11-08 18:17 | CC:PHRX | Pharmadrug Inc (2) | 0.05 | News Release200 | Pharmadrug grants options to buy 6.25 million shares |
| 2023-11-07 13:28 | CC:PHRX | Pharmadrug Inc (2) | 0.055 | News Release200 | Pharmadrug closes Securedose Synthetics acquisition |
| 2023-10-27 09:59 | CC:PHRX | Pharmadrug Inc (2) | 0.055 | News Release200 | Pharmadrug to acquire Securedose Synthetics |
| 2023-10-20 19:02 | CC:PHRX | Pharmadrug Inc | 0.005 | Rollback291 | Pharmadrug 1:7 rollback |
| 2023-10-20 14:12 | CC:PHRX | Pharmadrug Inc | 0.005 | News Release200 | Pharmadrug arranges 1:7 rollback, appoints Appleby CFO |
| 2023-09-19 16:19 | CC:PHRX | Pharmadrug Inc | 0.01 | News Release200 | Pharmadrug names Steen as AGM director nominee |
| 2023-09-14 14:03 | CC:PHRX | Pharmadrug Inc | 0.005 | News Release200 | Pharmadrug prepares for cepharanthine clinical batches |
| 2023-09-06 14:13 | CC:PHRX | Pharmadrug Inc | 0.01 | News Release200 | Pharmadrug appoints Steen as CEO, chairman |
| 2023-08-23 18:22 | CC:PHRX | Pharmadrug Inc | 0.005 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-08-23 18:20 | CC:PHRX | Pharmadrug Inc | 0.005 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-07-18 13:12 | CC:PHRX | Pharmadrug Inc | 0.005 | News Release200 | Pharmadrug investor to acquire 49% of Sairiyo |
| 2023-07-05 16:40 | CC:PHRX | Pharmadrug Inc | 0.01 | News Release200 | Pharmadrug terminates general security agreement |
| 2023-05-25 16:15 | CC:PHRX | Pharmadrug Inc | 0.01 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-25 16:15 | CC:PHRX | Pharmadrug Inc | 0.01 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-23 14:41 | CC:PHRX | Pharmadrug Inc | 0.005 | News Release200 | Pharmadrug names Posner adviser; CSO resigns |